AMSPARITY Trademark

Trademark Overview

On Thursday, October 1, 2020, a trademark application was filed for AMSPARITY with the United States Patent and Trademark Office. The USPTO has given the AMSPARITY trademark a serial number of 90229271. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 20, 2024. This trademark is owned by Pfizer Inc.. The AMSPARITY trademark is filed in the Pharmaceutical Products category with the following description:

Syringes sold filled with pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis; Injectors sold filled with pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis
amsparity

General Information

Serial Number90229271
Word MarkAMSPARITY
Filing DateThursday, October 1, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Goods and ServicesSyringes sold filled with pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis; Injectors sold filled with pharmaceutical preparations for the treatment of autoimmune diseases, rheumatoid arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, October 5, 2020NEW APPLICATION ENTERED
Monday, November 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Tuesday, January 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021SOU EXTENSION 1 FILED
Tuesday, September 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 28, 2021SOU EXTENSION 1 GRANTED
Thursday, September 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU EXTENSION 3 FILED
Wednesday, September 28, 2022SOU EXTENSION 3 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 28, 2022SOU EXTENSION 2 FILED
Monday, March 28, 2022SOU EXTENSION 2 GRANTED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 17, 2023SOU EXTENSION 4 FILED
Friday, March 17, 2023SOU EXTENSION 4 GRANTED
Tuesday, March 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 14, 2023SOU EXTENSION 5 FILED
Thursday, September 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 21, 2023SOU EXTENSION 5 GRANTED
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

amsparity arthritis ulcerative disease colitis crohn psoriatic idiopathic juvenile spondylitis ankylosing